Birth Country Influences the Choice of Antiretroviral Therapy in HIV-Infected Individuals: Experience From a French HIV Centre Article Swipe
Romain Palich
,
Rachid Agher
,
Dimoke J. Wetshikoy
,
Lise Cuzin
,
Sophie Seang
,
Cathia Soulié
,
Roland Tubiana
,
Marc‐Antoine Valantin
,
Luminita Schneider
,
Valérie Pourcher
,
Anne‐Geneviève Marcelin
,
Lambert Assoumou
,
Christine Katlama
·
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.1097/qai.0000000000003114
YOU?
·
· 2022
· Open Access
·
· DOI: https://doi.org/10.1097/qai.0000000000003114
Objectives: To assess whether antiretroviral therapy (ART) prescriptions differ between naive and virally suppressed HIV patients born in France (PBFs) and in Sub-Saharan Africa (PBSSAs). Setting: Observational single-center study. Methods: We included all PBFs and PBSSAs who entered into care at Pitié-Salpêtrière Hospital, Paris, France, from 01/01/2000 to 31/12/2018, with plasma HIV-RNA>200 copies/mL. We first compared the initial ART in naive PBFs and PBSSAs. Second, we compared the last-prescribed ART (including drug-reduced ART: daily 2-drug regimens, daily 1-drug regimens and intermittent 3-drug regimens) in virally suppressed PBFs and PBSSAs, by focusing on patients in care in 2018 with HIV-RNA <50 copies for at least 24 months. A univariable and multivariable logistic regression model was used to assess the impact of geographical origin on ART prescriptions. Results: A total of 1944 naive patients were included (915 PBSSAs and 1029 PBFs). PBSSAs were more frequently women, hepatitis B coinfected, with a lower pretherapeutic CD4 T-cell count, and most had tuberculosis at HIV diagnosis. After adjustment for confounders, PBSSAs were more likely to receive a first-line protease inhibitor-based regimen (OR 1.61, 95% CI: 1.31 to 1.98), and less likely to receive an integrase inhibitor-based regimen (OR 0.61, 95% CI: 0.42 to 0.88). Of the 968 virally suppressed patients (431 PBSSAs and 537 PBFs), PBSSAs were less likely to receive drug-reduced ART, including 2-drug regimens and intermittent three-drug regimens (OR 0.48, 95% CI: 0.36 to 0.65). Conclusions: Differences in ART prescriptions between PBSSAs and PBFs were not only explained by different clinical and virologic situations. Personal motivations of doctors in choosing ART according to country of birth need to be explored.
Related Topics
Concepts
Medicine
Regimen
Medical prescription
Logistic regression
Confounding
Internal medicine
Observational study
Viral load
Protease inhibitor (pharmacology)
Human immunodeficiency virus (HIV)
Antiretroviral therapy
Pediatrics
Surgery
Immunology
Pharmacology
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1097/qai.0000000000003114
- OA Status
- green
- Cited By
- 3
- References
- 48
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4306722674
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4306722674Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1097/qai.0000000000003114Digital Object Identifier
- Title
-
Birth Country Influences the Choice of Antiretroviral Therapy in HIV-Infected Individuals: Experience From a French HIV CentreWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2022Year of publication
- Publication date
-
2022-10-18Full publication date if available
- Authors
-
Romain Palich, Rachid Agher, Dimoke J. Wetshikoy, Lise Cuzin, Sophie Seang, Cathia Soulié, Roland Tubiana, Marc‐Antoine Valantin, Luminita Schneider, Valérie Pourcher, Anne‐Geneviève Marcelin, Lambert Assoumou, Christine KatlamaList of authors in order
- Landing page
-
https://doi.org/10.1097/qai.0000000000003114Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://hal.science/hal-03920903Direct OA link when available
- Concepts
-
Medicine, Regimen, Medical prescription, Logistic regression, Confounding, Internal medicine, Observational study, Viral load, Protease inhibitor (pharmacology), Human immunodeficiency virus (HIV), Antiretroviral therapy, Pediatrics, Surgery, Immunology, PharmacologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
3Total citation count in OpenAlex
- Citations by year (recent)
-
2023: 3Per-year citation counts (last 5 years)
- References (count)
-
48Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4306722674 |
|---|---|
| doi | https://doi.org/10.1097/qai.0000000000003114 |
| ids.doi | https://doi.org/10.1097/qai.0000000000003114 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/36257296 |
| ids.openalex | https://openalex.org/W4306722674 |
| fwci | 0.37554539 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D005260 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Female |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D006801 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Humans |
| mesh[2].qualifier_ui | Q000627 |
| mesh[2].descriptor_ui | D019380 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | therapeutic use |
| mesh[2].descriptor_name | Anti-HIV Agents |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D018791 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | CD4 Lymphocyte Count |
| mesh[4].qualifier_ui | Q000453 |
| mesh[4].descriptor_ui | D005602 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | epidemiology |
| mesh[4].descriptor_name | France |
| mesh[5].qualifier_ui | Q000188 |
| mesh[5].descriptor_ui | D015658 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | drug therapy |
| mesh[5].descriptor_name | HIV Infections |
| mesh[6].qualifier_ui | Q000453 |
| mesh[6].descriptor_ui | D015658 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | epidemiology |
| mesh[6].descriptor_name | HIV Infections |
| mesh[7].qualifier_ui | Q000627 |
| mesh[7].descriptor_ui | D019428 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | therapeutic use |
| mesh[7].descriptor_name | HIV Integrase Inhibitors |
| mesh[8].qualifier_ui | Q000627 |
| mesh[8].descriptor_ui | D012313 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | therapeutic use |
| mesh[8].descriptor_name | RNA |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D019562 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Viral Load |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D017954 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Africa South of the Sahara |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D008297 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Male |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D005260 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Female |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D006801 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Humans |
| mesh[14].qualifier_ui | Q000627 |
| mesh[14].descriptor_ui | D019380 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | therapeutic use |
| mesh[14].descriptor_name | Anti-HIV Agents |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D018791 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | CD4 Lymphocyte Count |
| mesh[16].qualifier_ui | Q000453 |
| mesh[16].descriptor_ui | D005602 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | epidemiology |
| mesh[16].descriptor_name | France |
| mesh[17].qualifier_ui | Q000188 |
| mesh[17].descriptor_ui | D015658 |
| mesh[17].is_major_topic | True |
| mesh[17].qualifier_name | drug therapy |
| mesh[17].descriptor_name | HIV Infections |
| mesh[18].qualifier_ui | Q000453 |
| mesh[18].descriptor_ui | D015658 |
| mesh[18].is_major_topic | True |
| mesh[18].qualifier_name | epidemiology |
| mesh[18].descriptor_name | HIV Infections |
| mesh[19].qualifier_ui | Q000627 |
| mesh[19].descriptor_ui | D019428 |
| mesh[19].is_major_topic | True |
| mesh[19].qualifier_name | therapeutic use |
| mesh[19].descriptor_name | HIV Integrase Inhibitors |
| mesh[20].qualifier_ui | Q000627 |
| mesh[20].descriptor_ui | D012313 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | therapeutic use |
| mesh[20].descriptor_name | RNA |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D019562 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Viral Load |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D017954 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Africa South of the Sahara |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D008297 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Male |
| type | article |
| title | Birth Country Influences the Choice of Antiretroviral Therapy in HIV-Infected Individuals: Experience From a French HIV Centre |
| biblio.issue | 2 |
| biblio.volume | 92 |
| biblio.last_page | 152 |
| biblio.first_page | 144 |
| topics[0].id | https://openalex.org/T10082 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | HIV/AIDS Research and Interventions |
| topics[1].id | https://openalex.org/T10526 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9993000030517578 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2725 |
| topics[1].subfield.display_name | Infectious Diseases |
| topics[1].display_name | HIV/AIDS drug development and treatment |
| topics[2].id | https://openalex.org/T10112 |
| topics[2].field.id | https://openalex.org/fields/24 |
| topics[2].field.display_name | Immunology and Microbiology |
| topics[2].score | 0.9983000159263611 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2406 |
| topics[2].subfield.display_name | Virology |
| topics[2].display_name | HIV Research and Treatment |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.7496601939201355 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2781413609 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7220539450645447 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q7308373 |
| concepts[1].display_name | Regimen |
| concepts[2].id | https://openalex.org/C2426938 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6172808408737183 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q3355478 |
| concepts[2].display_name | Medical prescription |
| concepts[3].id | https://openalex.org/C151956035 |
| concepts[3].level | 2 |
| concepts[3].score | 0.49193334579467773 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1132755 |
| concepts[3].display_name | Logistic regression |
| concepts[4].id | https://openalex.org/C77350462 |
| concepts[4].level | 2 |
| concepts[4].score | 0.4918491840362549 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1125472 |
| concepts[4].display_name | Confounding |
| concepts[5].id | https://openalex.org/C126322002 |
| concepts[5].level | 1 |
| concepts[5].score | 0.48427814245224 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[5].display_name | Internal medicine |
| concepts[6].id | https://openalex.org/C23131810 |
| concepts[6].level | 2 |
| concepts[6].score | 0.47123298048973083 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q818574 |
| concepts[6].display_name | Observational study |
| concepts[7].id | https://openalex.org/C142462285 |
| concepts[7].level | 3 |
| concepts[7].score | 0.4237232506275177 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q2528140 |
| concepts[7].display_name | Viral load |
| concepts[8].id | https://openalex.org/C2781143361 |
| concepts[8].level | 5 |
| concepts[8].score | 0.42060354351997375 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q55761529 |
| concepts[8].display_name | Protease inhibitor (pharmacology) |
| concepts[9].id | https://openalex.org/C3013748606 |
| concepts[9].level | 2 |
| concepts[9].score | 0.4075770378112793 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q15787 |
| concepts[9].display_name | Human immunodeficiency virus (HIV) |
| concepts[10].id | https://openalex.org/C2993143319 |
| concepts[10].level | 4 |
| concepts[10].score | 0.3625655770301819 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q583050 |
| concepts[10].display_name | Antiretroviral therapy |
| concepts[11].id | https://openalex.org/C187212893 |
| concepts[11].level | 1 |
| concepts[11].score | 0.34283190965652466 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q123028 |
| concepts[11].display_name | Pediatrics |
| concepts[12].id | https://openalex.org/C141071460 |
| concepts[12].level | 1 |
| concepts[12].score | 0.34054046869277954 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q40821 |
| concepts[12].display_name | Surgery |
| concepts[13].id | https://openalex.org/C203014093 |
| concepts[13].level | 1 |
| concepts[13].score | 0.2622799575328827 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[13].display_name | Immunology |
| concepts[14].id | https://openalex.org/C98274493 |
| concepts[14].level | 1 |
| concepts[14].score | 0.18032634258270264 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[14].display_name | Pharmacology |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.7496601939201355 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/regimen |
| keywords[1].score | 0.7220539450645447 |
| keywords[1].display_name | Regimen |
| keywords[2].id | https://openalex.org/keywords/medical-prescription |
| keywords[2].score | 0.6172808408737183 |
| keywords[2].display_name | Medical prescription |
| keywords[3].id | https://openalex.org/keywords/logistic-regression |
| keywords[3].score | 0.49193334579467773 |
| keywords[3].display_name | Logistic regression |
| keywords[4].id | https://openalex.org/keywords/confounding |
| keywords[4].score | 0.4918491840362549 |
| keywords[4].display_name | Confounding |
| keywords[5].id | https://openalex.org/keywords/internal-medicine |
| keywords[5].score | 0.48427814245224 |
| keywords[5].display_name | Internal medicine |
| keywords[6].id | https://openalex.org/keywords/observational-study |
| keywords[6].score | 0.47123298048973083 |
| keywords[6].display_name | Observational study |
| keywords[7].id | https://openalex.org/keywords/viral-load |
| keywords[7].score | 0.4237232506275177 |
| keywords[7].display_name | Viral load |
| keywords[8].id | https://openalex.org/keywords/protease-inhibitor |
| keywords[8].score | 0.42060354351997375 |
| keywords[8].display_name | Protease inhibitor (pharmacology) |
| keywords[9].id | https://openalex.org/keywords/human-immunodeficiency-virus |
| keywords[9].score | 0.4075770378112793 |
| keywords[9].display_name | Human immunodeficiency virus (HIV) |
| keywords[10].id | https://openalex.org/keywords/antiretroviral-therapy |
| keywords[10].score | 0.3625655770301819 |
| keywords[10].display_name | Antiretroviral therapy |
| keywords[11].id | https://openalex.org/keywords/pediatrics |
| keywords[11].score | 0.34283190965652466 |
| keywords[11].display_name | Pediatrics |
| keywords[12].id | https://openalex.org/keywords/surgery |
| keywords[12].score | 0.34054046869277954 |
| keywords[12].display_name | Surgery |
| keywords[13].id | https://openalex.org/keywords/immunology |
| keywords[13].score | 0.2622799575328827 |
| keywords[13].display_name | Immunology |
| keywords[14].id | https://openalex.org/keywords/pharmacology |
| keywords[14].score | 0.18032634258270264 |
| keywords[14].display_name | Pharmacology |
| language | en |
| locations[0].id | doi:10.1097/qai.0000000000003114 |
| locations[0].is_oa | False |
| locations[0].source.id | https://openalex.org/S157460402 |
| locations[0].source.issn | 1525-4135, 1944-7884 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1525-4135 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | JAIDS Journal of Acquired Immune Deficiency Syndromes |
| locations[0].source.host_organization | https://openalex.org/P4310315671 |
| locations[0].source.host_organization_name | Lippincott Williams & Wilkins |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310315671 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | JAIDS Journal of Acquired Immune Deficiency Syndromes |
| locations[0].landing_page_url | https://doi.org/10.1097/qai.0000000000003114 |
| locations[1].id | pmid:36257296 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Journal of acquired immune deficiency syndromes (1999) |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/36257296 |
| locations[2].id | pmh:oai:HAL:hal-03920903v1 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306402512 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | HAL (Le Centre pour la Communication Scientifique Directe) |
| locations[2].source.host_organization | https://openalex.org/I1294671590 |
| locations[2].source.host_organization_name | Centre National de la Recherche Scientifique |
| locations[2].source.host_organization_lineage | https://openalex.org/I1294671590 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Journal articles |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Journal of Acquired Immune Deficiency Syndromes - JAIDS, 2023, 92 (2), pp.144-152. ⟨10.1097/QAI.0000000000003114⟩ |
| locations[2].landing_page_url | https://hal.science/hal-03920903 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5034726375 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-0047-0101 |
| authorships[0].author.display_name | Romain Palich |
| authorships[0].countries | FR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210097159, https://openalex.org/I4210121705, https://openalex.org/I4210133907 |
| authorships[0].affiliations[0].raw_affiliation_string | Infectious Diseases Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France; |
| authorships[0].institutions[0].id | https://openalex.org/I4210097159 |
| authorships[0].institutions[0].ror | https://ror.org/00pg5jh14 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210097159 |
| authorships[0].institutions[0].country_code | FR |
| authorships[0].institutions[0].display_name | Assistance Publique – Hôpitaux de Paris |
| authorships[0].institutions[1].id | https://openalex.org/I154526488 |
| authorships[0].institutions[1].ror | https://ror.org/02vjkv261 |
| authorships[0].institutions[1].type | government |
| authorships[0].institutions[1].lineage | https://openalex.org/I154526488 |
| authorships[0].institutions[1].country_code | FR |
| authorships[0].institutions[1].display_name | Inserm |
| authorships[0].institutions[2].id | https://openalex.org/I4210133907 |
| authorships[0].institutions[2].ror | https://ror.org/02qqh1125 |
| authorships[0].institutions[2].type | facility |
| authorships[0].institutions[2].lineage | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210133907 |
| authorships[0].institutions[2].country_code | FR |
| authorships[0].institutions[2].display_name | Institut Pierre Louis d‘Épidémiologie et de Santé Publique |
| authorships[0].institutions[3].id | https://openalex.org/I4210121705 |
| authorships[0].institutions[3].ror | https://ror.org/02mh9a093 |
| authorships[0].institutions[3].type | healthcare |
| authorships[0].institutions[3].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210121705 |
| authorships[0].institutions[3].country_code | FR |
| authorships[0].institutions[3].display_name | Pitié-Salpêtrière Hospital |
| authorships[0].institutions[4].id | https://openalex.org/I39804081 |
| authorships[0].institutions[4].ror | https://ror.org/02en5vm52 |
| authorships[0].institutions[4].type | education |
| authorships[0].institutions[4].lineage | https://openalex.org/I39804081 |
| authorships[0].institutions[4].country_code | FR |
| authorships[0].institutions[4].display_name | Sorbonne Université |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Romain Palich |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Infectious Diseases Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France; |
| authorships[1].author.id | https://openalex.org/A5111626912 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Rachid Agher |
| authorships[1].countries | FR |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210097159, https://openalex.org/I4210121705, https://openalex.org/I4210133907 |
| authorships[1].affiliations[0].raw_affiliation_string | Infectious Diseases Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France; |
| authorships[1].institutions[0].id | https://openalex.org/I4210097159 |
| authorships[1].institutions[0].ror | https://ror.org/00pg5jh14 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210097159 |
| authorships[1].institutions[0].country_code | FR |
| authorships[1].institutions[0].display_name | Assistance Publique – Hôpitaux de Paris |
| authorships[1].institutions[1].id | https://openalex.org/I154526488 |
| authorships[1].institutions[1].ror | https://ror.org/02vjkv261 |
| authorships[1].institutions[1].type | government |
| authorships[1].institutions[1].lineage | https://openalex.org/I154526488 |
| authorships[1].institutions[1].country_code | FR |
| authorships[1].institutions[1].display_name | Inserm |
| authorships[1].institutions[2].id | https://openalex.org/I4210133907 |
| authorships[1].institutions[2].ror | https://ror.org/02qqh1125 |
| authorships[1].institutions[2].type | facility |
| authorships[1].institutions[2].lineage | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210133907 |
| authorships[1].institutions[2].country_code | FR |
| authorships[1].institutions[2].display_name | Institut Pierre Louis d‘Épidémiologie et de Santé Publique |
| authorships[1].institutions[3].id | https://openalex.org/I4210121705 |
| authorships[1].institutions[3].ror | https://ror.org/02mh9a093 |
| authorships[1].institutions[3].type | healthcare |
| authorships[1].institutions[3].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210121705 |
| authorships[1].institutions[3].country_code | FR |
| authorships[1].institutions[3].display_name | Pitié-Salpêtrière Hospital |
| authorships[1].institutions[4].id | https://openalex.org/I39804081 |
| authorships[1].institutions[4].ror | https://ror.org/02en5vm52 |
| authorships[1].institutions[4].type | education |
| authorships[1].institutions[4].lineage | https://openalex.org/I39804081 |
| authorships[1].institutions[4].country_code | FR |
| authorships[1].institutions[4].display_name | Sorbonne Université |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Rachid Agher |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Infectious Diseases Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France; |
| authorships[2].author.id | https://openalex.org/A5040253002 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Dimoke J. Wetshikoy |
| authorships[2].countries | FR |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210133907 |
| authorships[2].affiliations[0].raw_affiliation_string | Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France; |
| authorships[2].institutions[0].id | https://openalex.org/I154526488 |
| authorships[2].institutions[0].ror | https://ror.org/02vjkv261 |
| authorships[2].institutions[0].type | government |
| authorships[2].institutions[0].lineage | https://openalex.org/I154526488 |
| authorships[2].institutions[0].country_code | FR |
| authorships[2].institutions[0].display_name | Inserm |
| authorships[2].institutions[1].id | https://openalex.org/I4210133907 |
| authorships[2].institutions[1].ror | https://ror.org/02qqh1125 |
| authorships[2].institutions[1].type | facility |
| authorships[2].institutions[1].lineage | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210133907 |
| authorships[2].institutions[1].country_code | FR |
| authorships[2].institutions[1].display_name | Institut Pierre Louis d‘Épidémiologie et de Santé Publique |
| authorships[2].institutions[2].id | https://openalex.org/I39804081 |
| authorships[2].institutions[2].ror | https://ror.org/02en5vm52 |
| authorships[2].institutions[2].type | education |
| authorships[2].institutions[2].lineage | https://openalex.org/I39804081 |
| authorships[2].institutions[2].country_code | FR |
| authorships[2].institutions[2].display_name | Sorbonne Université |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Dimoke J. Wetshikoy |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France; |
| authorships[3].author.id | https://openalex.org/A5060353319 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-6345-497X |
| authorships[3].author.display_name | Lise Cuzin |
| authorships[3].countries | FR |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I134560555, https://openalex.org/I154526488 |
| authorships[3].affiliations[0].raw_affiliation_string | CERPOP, INSERM UMR1295, Paul Sabatier University, Toulouse, France |
| authorships[3].affiliations[1].institution_ids | https://openalex.org/I134560555, https://openalex.org/I154526488 |
| authorships[3].affiliations[1].raw_affiliation_string | Martinique University Hospital, Infectious and Tropical Diseases, Fort-De-France, FWI; CERPOP, INSERM UMR1295, Paul Sabatier University, Toulouse, France; and |
| authorships[3].institutions[0].id | https://openalex.org/I154526488 |
| authorships[3].institutions[0].ror | https://ror.org/02vjkv261 |
| authorships[3].institutions[0].type | government |
| authorships[3].institutions[0].lineage | https://openalex.org/I154526488 |
| authorships[3].institutions[0].country_code | FR |
| authorships[3].institutions[0].display_name | Inserm |
| authorships[3].institutions[1].id | https://openalex.org/I134560555 |
| authorships[3].institutions[1].ror | https://ror.org/02v6kpv12 |
| authorships[3].institutions[1].type | education |
| authorships[3].institutions[1].lineage | https://openalex.org/I134560555, https://openalex.org/I4412460029 |
| authorships[3].institutions[1].country_code | FR |
| authorships[3].institutions[1].display_name | Université Toulouse III - Paul Sabatier |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Lise Cuzin |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | CERPOP, INSERM UMR1295, Paul Sabatier University, Toulouse, France, Martinique University Hospital, Infectious and Tropical Diseases, Fort-De-France, FWI; CERPOP, INSERM UMR1295, Paul Sabatier University, Toulouse, France; and |
| authorships[4].author.id | https://openalex.org/A5107092484 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Sophie Seang |
| authorships[4].countries | FR |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210097159, https://openalex.org/I4210121705, https://openalex.org/I4210133907 |
| authorships[4].affiliations[0].raw_affiliation_string | Infectious Diseases Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France; |
| authorships[4].institutions[0].id | https://openalex.org/I4210097159 |
| authorships[4].institutions[0].ror | https://ror.org/00pg5jh14 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210097159 |
| authorships[4].institutions[0].country_code | FR |
| authorships[4].institutions[0].display_name | Assistance Publique – Hôpitaux de Paris |
| authorships[4].institutions[1].id | https://openalex.org/I154526488 |
| authorships[4].institutions[1].ror | https://ror.org/02vjkv261 |
| authorships[4].institutions[1].type | government |
| authorships[4].institutions[1].lineage | https://openalex.org/I154526488 |
| authorships[4].institutions[1].country_code | FR |
| authorships[4].institutions[1].display_name | Inserm |
| authorships[4].institutions[2].id | https://openalex.org/I4210133907 |
| authorships[4].institutions[2].ror | https://ror.org/02qqh1125 |
| authorships[4].institutions[2].type | facility |
| authorships[4].institutions[2].lineage | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210133907 |
| authorships[4].institutions[2].country_code | FR |
| authorships[4].institutions[2].display_name | Institut Pierre Louis d‘Épidémiologie et de Santé Publique |
| authorships[4].institutions[3].id | https://openalex.org/I4210121705 |
| authorships[4].institutions[3].ror | https://ror.org/02mh9a093 |
| authorships[4].institutions[3].type | healthcare |
| authorships[4].institutions[3].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210121705 |
| authorships[4].institutions[3].country_code | FR |
| authorships[4].institutions[3].display_name | Pitié-Salpêtrière Hospital |
| authorships[4].institutions[4].id | https://openalex.org/I39804081 |
| authorships[4].institutions[4].ror | https://ror.org/02en5vm52 |
| authorships[4].institutions[4].type | education |
| authorships[4].institutions[4].lineage | https://openalex.org/I39804081 |
| authorships[4].institutions[4].country_code | FR |
| authorships[4].institutions[4].display_name | Sorbonne Université |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Sophie Seang |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Infectious Diseases Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France; |
| authorships[5].author.id | https://openalex.org/A5113691687 |
| authorships[5].author.orcid | https://orcid.org/0009-0008-2032-4148 |
| authorships[5].author.display_name | Cathia Soulié |
| authorships[5].countries | FR |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210097159, https://openalex.org/I4210121705, https://openalex.org/I4210133907 |
| authorships[5].affiliations[0].raw_affiliation_string | Virology Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France. |
| authorships[5].institutions[0].id | https://openalex.org/I4210097159 |
| authorships[5].institutions[0].ror | https://ror.org/00pg5jh14 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210097159 |
| authorships[5].institutions[0].country_code | FR |
| authorships[5].institutions[0].display_name | Assistance Publique – Hôpitaux de Paris |
| authorships[5].institutions[1].id | https://openalex.org/I154526488 |
| authorships[5].institutions[1].ror | https://ror.org/02vjkv261 |
| authorships[5].institutions[1].type | government |
| authorships[5].institutions[1].lineage | https://openalex.org/I154526488 |
| authorships[5].institutions[1].country_code | FR |
| authorships[5].institutions[1].display_name | Inserm |
| authorships[5].institutions[2].id | https://openalex.org/I4210133907 |
| authorships[5].institutions[2].ror | https://ror.org/02qqh1125 |
| authorships[5].institutions[2].type | facility |
| authorships[5].institutions[2].lineage | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210133907 |
| authorships[5].institutions[2].country_code | FR |
| authorships[5].institutions[2].display_name | Institut Pierre Louis d‘Épidémiologie et de Santé Publique |
| authorships[5].institutions[3].id | https://openalex.org/I4210121705 |
| authorships[5].institutions[3].ror | https://ror.org/02mh9a093 |
| authorships[5].institutions[3].type | healthcare |
| authorships[5].institutions[3].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210121705 |
| authorships[5].institutions[3].country_code | FR |
| authorships[5].institutions[3].display_name | Pitié-Salpêtrière Hospital |
| authorships[5].institutions[4].id | https://openalex.org/I39804081 |
| authorships[5].institutions[4].ror | https://ror.org/02en5vm52 |
| authorships[5].institutions[4].type | education |
| authorships[5].institutions[4].lineage | https://openalex.org/I39804081 |
| authorships[5].institutions[4].country_code | FR |
| authorships[5].institutions[4].display_name | Sorbonne Université |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Cathia Soulie |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Virology Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France. |
| authorships[6].author.id | https://openalex.org/A5107599945 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Roland Tubiana |
| authorships[6].countries | FR |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210097159, https://openalex.org/I4210121705, https://openalex.org/I4210133907 |
| authorships[6].affiliations[0].raw_affiliation_string | Infectious Diseases Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France; |
| authorships[6].institutions[0].id | https://openalex.org/I4210097159 |
| authorships[6].institutions[0].ror | https://ror.org/00pg5jh14 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210097159 |
| authorships[6].institutions[0].country_code | FR |
| authorships[6].institutions[0].display_name | Assistance Publique – Hôpitaux de Paris |
| authorships[6].institutions[1].id | https://openalex.org/I154526488 |
| authorships[6].institutions[1].ror | https://ror.org/02vjkv261 |
| authorships[6].institutions[1].type | government |
| authorships[6].institutions[1].lineage | https://openalex.org/I154526488 |
| authorships[6].institutions[1].country_code | FR |
| authorships[6].institutions[1].display_name | Inserm |
| authorships[6].institutions[2].id | https://openalex.org/I4210133907 |
| authorships[6].institutions[2].ror | https://ror.org/02qqh1125 |
| authorships[6].institutions[2].type | facility |
| authorships[6].institutions[2].lineage | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210133907 |
| authorships[6].institutions[2].country_code | FR |
| authorships[6].institutions[2].display_name | Institut Pierre Louis d‘Épidémiologie et de Santé Publique |
| authorships[6].institutions[3].id | https://openalex.org/I4210121705 |
| authorships[6].institutions[3].ror | https://ror.org/02mh9a093 |
| authorships[6].institutions[3].type | healthcare |
| authorships[6].institutions[3].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210121705 |
| authorships[6].institutions[3].country_code | FR |
| authorships[6].institutions[3].display_name | Pitié-Salpêtrière Hospital |
| authorships[6].institutions[4].id | https://openalex.org/I39804081 |
| authorships[6].institutions[4].ror | https://ror.org/02en5vm52 |
| authorships[6].institutions[4].type | education |
| authorships[6].institutions[4].lineage | https://openalex.org/I39804081 |
| authorships[6].institutions[4].country_code | FR |
| authorships[6].institutions[4].display_name | Sorbonne Université |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Roland Tubiana |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Infectious Diseases Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France; |
| authorships[7].author.id | https://openalex.org/A5053097790 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Marc‐Antoine Valantin |
| authorships[7].countries | FR |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210097159, https://openalex.org/I4210121705, https://openalex.org/I4210133907 |
| authorships[7].affiliations[0].raw_affiliation_string | Infectious Diseases Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France; |
| authorships[7].institutions[0].id | https://openalex.org/I4210097159 |
| authorships[7].institutions[0].ror | https://ror.org/00pg5jh14 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210097159 |
| authorships[7].institutions[0].country_code | FR |
| authorships[7].institutions[0].display_name | Assistance Publique – Hôpitaux de Paris |
| authorships[7].institutions[1].id | https://openalex.org/I154526488 |
| authorships[7].institutions[1].ror | https://ror.org/02vjkv261 |
| authorships[7].institutions[1].type | government |
| authorships[7].institutions[1].lineage | https://openalex.org/I154526488 |
| authorships[7].institutions[1].country_code | FR |
| authorships[7].institutions[1].display_name | Inserm |
| authorships[7].institutions[2].id | https://openalex.org/I4210133907 |
| authorships[7].institutions[2].ror | https://ror.org/02qqh1125 |
| authorships[7].institutions[2].type | facility |
| authorships[7].institutions[2].lineage | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210133907 |
| authorships[7].institutions[2].country_code | FR |
| authorships[7].institutions[2].display_name | Institut Pierre Louis d‘Épidémiologie et de Santé Publique |
| authorships[7].institutions[3].id | https://openalex.org/I4210121705 |
| authorships[7].institutions[3].ror | https://ror.org/02mh9a093 |
| authorships[7].institutions[3].type | healthcare |
| authorships[7].institutions[3].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210121705 |
| authorships[7].institutions[3].country_code | FR |
| authorships[7].institutions[3].display_name | Pitié-Salpêtrière Hospital |
| authorships[7].institutions[4].id | https://openalex.org/I39804081 |
| authorships[7].institutions[4].ror | https://ror.org/02en5vm52 |
| authorships[7].institutions[4].type | education |
| authorships[7].institutions[4].lineage | https://openalex.org/I39804081 |
| authorships[7].institutions[4].country_code | FR |
| authorships[7].institutions[4].display_name | Sorbonne Université |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Marc-Antoine Valantin |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Infectious Diseases Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France; |
| authorships[8].author.id | https://openalex.org/A5110093029 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Luminita Schneider |
| authorships[8].countries | FR |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210097159, https://openalex.org/I4210121705, https://openalex.org/I4210133907 |
| authorships[8].affiliations[0].raw_affiliation_string | Infectious Diseases Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France; |
| authorships[8].institutions[0].id | https://openalex.org/I4210097159 |
| authorships[8].institutions[0].ror | https://ror.org/00pg5jh14 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210097159 |
| authorships[8].institutions[0].country_code | FR |
| authorships[8].institutions[0].display_name | Assistance Publique – Hôpitaux de Paris |
| authorships[8].institutions[1].id | https://openalex.org/I154526488 |
| authorships[8].institutions[1].ror | https://ror.org/02vjkv261 |
| authorships[8].institutions[1].type | government |
| authorships[8].institutions[1].lineage | https://openalex.org/I154526488 |
| authorships[8].institutions[1].country_code | FR |
| authorships[8].institutions[1].display_name | Inserm |
| authorships[8].institutions[2].id | https://openalex.org/I4210133907 |
| authorships[8].institutions[2].ror | https://ror.org/02qqh1125 |
| authorships[8].institutions[2].type | facility |
| authorships[8].institutions[2].lineage | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210133907 |
| authorships[8].institutions[2].country_code | FR |
| authorships[8].institutions[2].display_name | Institut Pierre Louis d‘Épidémiologie et de Santé Publique |
| authorships[8].institutions[3].id | https://openalex.org/I4210121705 |
| authorships[8].institutions[3].ror | https://ror.org/02mh9a093 |
| authorships[8].institutions[3].type | healthcare |
| authorships[8].institutions[3].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210121705 |
| authorships[8].institutions[3].country_code | FR |
| authorships[8].institutions[3].display_name | Pitié-Salpêtrière Hospital |
| authorships[8].institutions[4].id | https://openalex.org/I39804081 |
| authorships[8].institutions[4].ror | https://ror.org/02en5vm52 |
| authorships[8].institutions[4].type | education |
| authorships[8].institutions[4].lineage | https://openalex.org/I39804081 |
| authorships[8].institutions[4].country_code | FR |
| authorships[8].institutions[4].display_name | Sorbonne Université |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Luminita Schneider |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Infectious Diseases Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France; |
| authorships[9].author.id | https://openalex.org/A5112343546 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Valérie Pourcher |
| authorships[9].countries | FR |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210097159, https://openalex.org/I4210121705, https://openalex.org/I4210133907 |
| authorships[9].affiliations[0].raw_affiliation_string | Infectious Diseases Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France; |
| authorships[9].institutions[0].id | https://openalex.org/I4210097159 |
| authorships[9].institutions[0].ror | https://ror.org/00pg5jh14 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210097159 |
| authorships[9].institutions[0].country_code | FR |
| authorships[9].institutions[0].display_name | Assistance Publique – Hôpitaux de Paris |
| authorships[9].institutions[1].id | https://openalex.org/I154526488 |
| authorships[9].institutions[1].ror | https://ror.org/02vjkv261 |
| authorships[9].institutions[1].type | government |
| authorships[9].institutions[1].lineage | https://openalex.org/I154526488 |
| authorships[9].institutions[1].country_code | FR |
| authorships[9].institutions[1].display_name | Inserm |
| authorships[9].institutions[2].id | https://openalex.org/I4210133907 |
| authorships[9].institutions[2].ror | https://ror.org/02qqh1125 |
| authorships[9].institutions[2].type | facility |
| authorships[9].institutions[2].lineage | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210133907 |
| authorships[9].institutions[2].country_code | FR |
| authorships[9].institutions[2].display_name | Institut Pierre Louis d‘Épidémiologie et de Santé Publique |
| authorships[9].institutions[3].id | https://openalex.org/I4210121705 |
| authorships[9].institutions[3].ror | https://ror.org/02mh9a093 |
| authorships[9].institutions[3].type | healthcare |
| authorships[9].institutions[3].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210121705 |
| authorships[9].institutions[3].country_code | FR |
| authorships[9].institutions[3].display_name | Pitié-Salpêtrière Hospital |
| authorships[9].institutions[4].id | https://openalex.org/I39804081 |
| authorships[9].institutions[4].ror | https://ror.org/02en5vm52 |
| authorships[9].institutions[4].type | education |
| authorships[9].institutions[4].lineage | https://openalex.org/I39804081 |
| authorships[9].institutions[4].country_code | FR |
| authorships[9].institutions[4].display_name | Sorbonne Université |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Valérie Pourcher |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Infectious Diseases Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France; |
| authorships[10].author.id | https://openalex.org/A5043721868 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Anne‐Geneviève Marcelin |
| authorships[10].countries | FR |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210097159, https://openalex.org/I4210121705, https://openalex.org/I4210133907 |
| authorships[10].affiliations[0].raw_affiliation_string | Virology Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France. |
| authorships[10].institutions[0].id | https://openalex.org/I4210097159 |
| authorships[10].institutions[0].ror | https://ror.org/00pg5jh14 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210097159 |
| authorships[10].institutions[0].country_code | FR |
| authorships[10].institutions[0].display_name | Assistance Publique – Hôpitaux de Paris |
| authorships[10].institutions[1].id | https://openalex.org/I154526488 |
| authorships[10].institutions[1].ror | https://ror.org/02vjkv261 |
| authorships[10].institutions[1].type | government |
| authorships[10].institutions[1].lineage | https://openalex.org/I154526488 |
| authorships[10].institutions[1].country_code | FR |
| authorships[10].institutions[1].display_name | Inserm |
| authorships[10].institutions[2].id | https://openalex.org/I4210133907 |
| authorships[10].institutions[2].ror | https://ror.org/02qqh1125 |
| authorships[10].institutions[2].type | facility |
| authorships[10].institutions[2].lineage | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210133907 |
| authorships[10].institutions[2].country_code | FR |
| authorships[10].institutions[2].display_name | Institut Pierre Louis d‘Épidémiologie et de Santé Publique |
| authorships[10].institutions[3].id | https://openalex.org/I4210121705 |
| authorships[10].institutions[3].ror | https://ror.org/02mh9a093 |
| authorships[10].institutions[3].type | healthcare |
| authorships[10].institutions[3].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210121705 |
| authorships[10].institutions[3].country_code | FR |
| authorships[10].institutions[3].display_name | Pitié-Salpêtrière Hospital |
| authorships[10].institutions[4].id | https://openalex.org/I39804081 |
| authorships[10].institutions[4].ror | https://ror.org/02en5vm52 |
| authorships[10].institutions[4].type | education |
| authorships[10].institutions[4].lineage | https://openalex.org/I39804081 |
| authorships[10].institutions[4].country_code | FR |
| authorships[10].institutions[4].display_name | Sorbonne Université |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Anne-Geneviève Marcelin |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Virology Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France. |
| authorships[11].author.id | https://openalex.org/A5091495073 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-5547-1796 |
| authorships[11].author.display_name | Lambert Assoumou |
| authorships[11].countries | FR |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210133907 |
| authorships[11].affiliations[0].raw_affiliation_string | Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France; |
| authorships[11].institutions[0].id | https://openalex.org/I154526488 |
| authorships[11].institutions[0].ror | https://ror.org/02vjkv261 |
| authorships[11].institutions[0].type | government |
| authorships[11].institutions[0].lineage | https://openalex.org/I154526488 |
| authorships[11].institutions[0].country_code | FR |
| authorships[11].institutions[0].display_name | Inserm |
| authorships[11].institutions[1].id | https://openalex.org/I4210133907 |
| authorships[11].institutions[1].ror | https://ror.org/02qqh1125 |
| authorships[11].institutions[1].type | facility |
| authorships[11].institutions[1].lineage | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210133907 |
| authorships[11].institutions[1].country_code | FR |
| authorships[11].institutions[1].display_name | Institut Pierre Louis d‘Épidémiologie et de Santé Publique |
| authorships[11].institutions[2].id | https://openalex.org/I39804081 |
| authorships[11].institutions[2].ror | https://ror.org/02en5vm52 |
| authorships[11].institutions[2].type | education |
| authorships[11].institutions[2].lineage | https://openalex.org/I39804081 |
| authorships[11].institutions[2].country_code | FR |
| authorships[11].institutions[2].display_name | Sorbonne Université |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Lambert Assoumou |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France; |
| authorships[12].author.id | https://openalex.org/A5017386021 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-5093-4800 |
| authorships[12].author.display_name | Christine Katlama |
| authorships[12].countries | FR |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210097159, https://openalex.org/I4210121705, https://openalex.org/I4210133907 |
| authorships[12].affiliations[0].raw_affiliation_string | Infectious Diseases Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France; |
| authorships[12].institutions[0].id | https://openalex.org/I4210097159 |
| authorships[12].institutions[0].ror | https://ror.org/00pg5jh14 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I4210097159 |
| authorships[12].institutions[0].country_code | FR |
| authorships[12].institutions[0].display_name | Assistance Publique – Hôpitaux de Paris |
| authorships[12].institutions[1].id | https://openalex.org/I154526488 |
| authorships[12].institutions[1].ror | https://ror.org/02vjkv261 |
| authorships[12].institutions[1].type | government |
| authorships[12].institutions[1].lineage | https://openalex.org/I154526488 |
| authorships[12].institutions[1].country_code | FR |
| authorships[12].institutions[1].display_name | Inserm |
| authorships[12].institutions[2].id | https://openalex.org/I4210133907 |
| authorships[12].institutions[2].ror | https://ror.org/02qqh1125 |
| authorships[12].institutions[2].type | facility |
| authorships[12].institutions[2].lineage | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210133907 |
| authorships[12].institutions[2].country_code | FR |
| authorships[12].institutions[2].display_name | Institut Pierre Louis d‘Épidémiologie et de Santé Publique |
| authorships[12].institutions[3].id | https://openalex.org/I4210121705 |
| authorships[12].institutions[3].ror | https://ror.org/02mh9a093 |
| authorships[12].institutions[3].type | healthcare |
| authorships[12].institutions[3].lineage | https://openalex.org/I4210097159, https://openalex.org/I4210121705 |
| authorships[12].institutions[3].country_code | FR |
| authorships[12].institutions[3].display_name | Pitié-Salpêtrière Hospital |
| authorships[12].institutions[4].id | https://openalex.org/I39804081 |
| authorships[12].institutions[4].ror | https://ror.org/02en5vm52 |
| authorships[12].institutions[4].type | education |
| authorships[12].institutions[4].lineage | https://openalex.org/I39804081 |
| authorships[12].institutions[4].country_code | FR |
| authorships[12].institutions[4].display_name | Sorbonne Université |
| authorships[12].author_position | last |
| authorships[12].raw_author_name | Christine Katlama |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Infectious Diseases Department, Pitié-Salpêtrière Hospital, AP-HP, Pierre Louis Epidemiology and Public Health Institute (iPLESP), INSERM 1136, Sorbonne University, Paris, France; |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://hal.science/hal-03920903 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Birth Country Influences the Choice of Antiretroviral Therapy in HIV-Infected Individuals: Experience From a French HIV Centre |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10082 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | HIV/AIDS Research and Interventions |
| related_works | https://openalex.org/W2994176440, https://openalex.org/W4288713694, https://openalex.org/W2481749367, https://openalex.org/W830718730, https://openalex.org/W4291127547, https://openalex.org/W2507203385, https://openalex.org/W2021628412, https://openalex.org/W1979721624, https://openalex.org/W3028205985, https://openalex.org/W55393503 |
| cited_by_count | 3 |
| counts_by_year[0].year | 2023 |
| counts_by_year[0].cited_by_count | 3 |
| locations_count | 3 |
| best_oa_location.id | pmh:oai:HAL:hal-03920903v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4306402512 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | HAL (Le Centre pour la Communication Scientifique Directe) |
| best_oa_location.source.host_organization | https://openalex.org/I1294671590 |
| best_oa_location.source.host_organization_name | Centre National de la Recherche Scientifique |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I1294671590 |
| best_oa_location.license | other-oa |
| best_oa_location.pdf_url | |
| best_oa_location.version | submittedVersion |
| best_oa_location.raw_type | Journal articles |
| best_oa_location.license_id | https://openalex.org/licenses/other-oa |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | Journal of Acquired Immune Deficiency Syndromes - JAIDS, 2023, 92 (2), pp.144-152. ⟨10.1097/QAI.0000000000003114⟩ |
| best_oa_location.landing_page_url | https://hal.science/hal-03920903 |
| primary_location.id | doi:10.1097/qai.0000000000003114 |
| primary_location.is_oa | False |
| primary_location.source.id | https://openalex.org/S157460402 |
| primary_location.source.issn | 1525-4135, 1944-7884 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1525-4135 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | JAIDS Journal of Acquired Immune Deficiency Syndromes |
| primary_location.source.host_organization | https://openalex.org/P4310315671 |
| primary_location.source.host_organization_name | Lippincott Williams & Wilkins |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310315671 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | JAIDS Journal of Acquired Immune Deficiency Syndromes |
| primary_location.landing_page_url | https://doi.org/10.1097/qai.0000000000003114 |
| publication_date | 2022-10-18 |
| publication_year | 2022 |
| referenced_works | https://openalex.org/W3091955100, https://openalex.org/W2600324759, https://openalex.org/W4300052607, https://openalex.org/W2287047510, https://openalex.org/W2913613564, https://openalex.org/W2788805050, https://openalex.org/W2767120785, https://openalex.org/W2560506222, https://openalex.org/W1973366004, https://openalex.org/W2501252490, https://openalex.org/W2601064640, https://openalex.org/W2208513116, https://openalex.org/W2112861565, https://openalex.org/W2319591808, https://openalex.org/W2317876398, https://openalex.org/W3133587978, https://openalex.org/W2081148652, https://openalex.org/W2467069375, https://openalex.org/W2169167023, https://openalex.org/W2591925517, https://openalex.org/W1479756214, https://openalex.org/W2903503738, https://openalex.org/W2915119560, https://openalex.org/W1978364917, https://openalex.org/W3007468142, https://openalex.org/W6740226237, https://openalex.org/W2767185943, https://openalex.org/W2403529429, https://openalex.org/W2068866500, https://openalex.org/W3000709627, https://openalex.org/W2959367164, https://openalex.org/W2729724518, https://openalex.org/W4210285994, https://openalex.org/W2145172939, https://openalex.org/W2145810626, https://openalex.org/W4210542427, https://openalex.org/W2918061732, https://openalex.org/W1985892520, https://openalex.org/W2318723339, https://openalex.org/W2140612461, https://openalex.org/W2090581395, https://openalex.org/W3198741210, https://openalex.org/W3118723522, https://openalex.org/W1990876766, https://openalex.org/W4200307875, https://openalex.org/W6648249163, https://openalex.org/W6805269606, https://openalex.org/W2733885492 |
| referenced_works_count | 48 |
| abstract_inverted_index.A | 106, 126 |
| abstract_inverted_index.B | 145 |
| abstract_inverted_index.a | 148, 171 |
| abstract_inverted_index.24 | 104 |
| abstract_inverted_index.Of | 199 |
| abstract_inverted_index.To | 1 |
| abstract_inverted_index.We | 30, 53 |
| abstract_inverted_index.an | 188 |
| abstract_inverted_index.at | 40, 102, 158 |
| abstract_inverted_index.be | 265 |
| abstract_inverted_index.by | 89, 245 |
| abstract_inverted_index.in | 17, 21, 59, 83, 93, 95, 234, 255 |
| abstract_inverted_index.of | 119, 128, 253, 261 |
| abstract_inverted_index.on | 91, 122 |
| abstract_inverted_index.to | 47, 115, 169, 181, 186, 197, 214, 230, 259, 264 |
| abstract_inverted_index.we | 65 |
| abstract_inverted_index.(OR | 176, 192, 225 |
| abstract_inverted_index.537 | 208 |
| abstract_inverted_index.95% | 178, 194, 227 |
| abstract_inverted_index.968 | 201 |
| abstract_inverted_index.ART | 58, 69, 123, 235, 257 |
| abstract_inverted_index.CD4 | 151 |
| abstract_inverted_index.CI: | 179, 195, 228 |
| abstract_inverted_index.HIV | 14, 159 |
| abstract_inverted_index.all | 32 |
| abstract_inverted_index.and | 11, 20, 34, 62, 79, 87, 108, 136, 154, 183, 207, 221, 239, 248 |
| abstract_inverted_index.for | 101, 163 |
| abstract_inverted_index.had | 156 |
| abstract_inverted_index.not | 242 |
| abstract_inverted_index.the | 56, 67, 117, 200 |
| abstract_inverted_index.was | 113 |
| abstract_inverted_index.who | 36 |
| abstract_inverted_index.(431 | 205 |
| abstract_inverted_index.(915 | 134 |
| abstract_inverted_index.0.36 | 229 |
| abstract_inverted_index.0.42 | 196 |
| abstract_inverted_index.1.31 | 180 |
| abstract_inverted_index.1029 | 137 |
| abstract_inverted_index.1944 | 129 |
| abstract_inverted_index.2018 | 96 |
| abstract_inverted_index.ART, | 217 |
| abstract_inverted_index.ART: | 72 |
| abstract_inverted_index.PBFs | 33, 61, 86, 240 |
| abstract_inverted_index.born | 16 |
| abstract_inverted_index.care | 39, 94 |
| abstract_inverted_index.from | 45 |
| abstract_inverted_index.into | 38 |
| abstract_inverted_index.less | 184, 212 |
| abstract_inverted_index.more | 141, 167 |
| abstract_inverted_index.most | 155 |
| abstract_inverted_index.need | 263 |
| abstract_inverted_index.only | 243 |
| abstract_inverted_index.used | 114 |
| abstract_inverted_index.were | 132, 140, 166, 211, 241 |
| abstract_inverted_index.with | 49, 97, 147 |
| abstract_inverted_index.(ART) | 6 |
| abstract_inverted_index.0.48, | 226 |
| abstract_inverted_index.0.61, | 193 |
| abstract_inverted_index.1.61, | 177 |
| abstract_inverted_index.After | 161 |
| abstract_inverted_index.birth | 262 |
| abstract_inverted_index.daily | 73, 76 |
| abstract_inverted_index.first | 54 |
| abstract_inverted_index.least | 103 |
| abstract_inverted_index.lower | 149 |
| abstract_inverted_index.model | 112 |
| abstract_inverted_index.naive | 10, 60, 130 |
| abstract_inverted_index.total | 127 |
| abstract_inverted_index.<50 | 99 |
| abstract_inverted_index.(PBFs) | 19 |
| abstract_inverted_index.0.65). | 231 |
| abstract_inverted_index.0.88). | 198 |
| abstract_inverted_index.1-drug | 77 |
| abstract_inverted_index.1.98), | 182 |
| abstract_inverted_index.2-drug | 74, 219 |
| abstract_inverted_index.3-drug | 81 |
| abstract_inverted_index.Africa | 23 |
| abstract_inverted_index.France | 18 |
| abstract_inverted_index.PBFs), | 209 |
| abstract_inverted_index.PBFs). | 138 |
| abstract_inverted_index.PBSSAs | 35, 135, 139, 165, 206, 210, 238 |
| abstract_inverted_index.Paris, | 43 |
| abstract_inverted_index.T-cell | 152 |
| abstract_inverted_index.assess | 2, 116 |
| abstract_inverted_index.copies | 100 |
| abstract_inverted_index.count, | 153 |
| abstract_inverted_index.differ | 8 |
| abstract_inverted_index.impact | 118 |
| abstract_inverted_index.likely | 168, 185, 213 |
| abstract_inverted_index.origin | 121 |
| abstract_inverted_index.plasma | 50 |
| abstract_inverted_index.study. | 28 |
| abstract_inverted_index.women, | 143 |
| abstract_inverted_index.France, | 44 |
| abstract_inverted_index.HIV-RNA | 98 |
| abstract_inverted_index.PBSSAs, | 88 |
| abstract_inverted_index.PBSSAs. | 63 |
| abstract_inverted_index.Second, | 64 |
| abstract_inverted_index.between | 9, 237 |
| abstract_inverted_index.country | 260 |
| abstract_inverted_index.doctors | 254 |
| abstract_inverted_index.entered | 37 |
| abstract_inverted_index.initial | 57 |
| abstract_inverted_index.months. | 105 |
| abstract_inverted_index.receive | 170, 187, 215 |
| abstract_inverted_index.regimen | 175, 191 |
| abstract_inverted_index.therapy | 5 |
| abstract_inverted_index.virally | 12, 84, 202 |
| abstract_inverted_index.whether | 3 |
| abstract_inverted_index.Methods: | 29 |
| abstract_inverted_index.Personal | 251 |
| abstract_inverted_index.Results: | 125 |
| abstract_inverted_index.Setting: | 25 |
| abstract_inverted_index.choosing | 256 |
| abstract_inverted_index.clinical | 247 |
| abstract_inverted_index.compared | 55, 66 |
| abstract_inverted_index.focusing | 90 |
| abstract_inverted_index.included | 31, 133 |
| abstract_inverted_index.logistic | 110 |
| abstract_inverted_index.patients | 15, 92, 131, 204 |
| abstract_inverted_index.protease | 173 |
| abstract_inverted_index.regimens | 78, 220, 224 |
| abstract_inverted_index.(PBSSAs). | 24 |
| abstract_inverted_index.Hospital, | 42 |
| abstract_inverted_index.according | 258 |
| abstract_inverted_index.different | 246 |
| abstract_inverted_index.explained | 244 |
| abstract_inverted_index.explored. | 266 |
| abstract_inverted_index.hepatitis | 144 |
| abstract_inverted_index.including | 218 |
| abstract_inverted_index.integrase | 189 |
| abstract_inverted_index.regimens) | 82 |
| abstract_inverted_index.regimens, | 75 |
| abstract_inverted_index.virologic | 249 |
| abstract_inverted_index.(including | 70 |
| abstract_inverted_index.01/01/2000 | 46 |
| abstract_inverted_index.adjustment | 162 |
| abstract_inverted_index.copies/mL. | 52 |
| abstract_inverted_index.diagnosis. | 160 |
| abstract_inverted_index.first-line | 172 |
| abstract_inverted_index.frequently | 142 |
| abstract_inverted_index.regression | 111 |
| abstract_inverted_index.suppressed | 13, 85, 203 |
| abstract_inverted_index.three-drug | 223 |
| abstract_inverted_index.31/12/2018, | 48 |
| abstract_inverted_index.Differences | 233 |
| abstract_inverted_index.Objectives: | 0 |
| abstract_inverted_index.Sub-Saharan | 22 |
| abstract_inverted_index.coinfected, | 146 |
| abstract_inverted_index.motivations | 252 |
| abstract_inverted_index.situations. | 250 |
| abstract_inverted_index.univariable | 107 |
| abstract_inverted_index.Conclusions: | 232 |
| abstract_inverted_index.confounders, | 164 |
| abstract_inverted_index.drug-reduced | 71, 216 |
| abstract_inverted_index.geographical | 120 |
| abstract_inverted_index.intermittent | 80, 222 |
| abstract_inverted_index.tuberculosis | 157 |
| abstract_inverted_index.Observational | 26 |
| abstract_inverted_index.multivariable | 109 |
| abstract_inverted_index.prescriptions | 7, 236 |
| abstract_inverted_index.single-center | 27 |
| abstract_inverted_index.HIV-RNA>200 | 51 |
| abstract_inverted_index.antiretroviral | 4 |
| abstract_inverted_index.prescriptions. | 124 |
| abstract_inverted_index.pretherapeutic | 150 |
| abstract_inverted_index.inhibitor-based | 174, 190 |
| abstract_inverted_index.last-prescribed | 68 |
| abstract_inverted_index.Pitié-Salpêtrière | 41 |
| cited_by_percentile_year.max | 97 |
| cited_by_percentile_year.min | 96 |
| corresponding_author_ids | https://openalex.org/A5034726375 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 13 |
| corresponding_institution_ids | https://openalex.org/I154526488, https://openalex.org/I39804081, https://openalex.org/I4210097159, https://openalex.org/I4210121705, https://openalex.org/I4210133907 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8600000143051147 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.58258405 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |